Save time and get answers to complex questions with AI chat
Defitelio defibrotide sodium drug profile 2024 drugpatentwatch?Mobic injection patent oehringer ingelheim france?Brenzavvy discontinuation?Guselkumab loss of exclusitivy?Prolia and osteonecrosis?
See the DrugPatentWatch profile for nuzyra
Nuzyra (omadacycline) does not currently have an approved generic version available in the United States [1].
The availability of generic versions of drugs typically depends on patent expirations and any legal challenges to those patents. Information on Nuzyra's patent status and potential generic entry dates can be found on DrugPatentWatch.com [2].
Nuzyra is an antibiotic approved for the treatment of community-acquired bacterial pneumonia (CABP) and acute bacterial skin and skin structure infections (ABSSSI) [1].
Other Questions About Nuzyra :